Article metrics

Download PDFPDF

291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to May 2022

AbstractFullPdf
Nov 2020187029
Dec 20203806
Jan 202148013
Feb 2021104018
Mar 2021190028
Apr 2021204024
May 202183021
Jun 20210019
Jul 20210013
Aug 20210011
Sep 20210012
Oct 202194024
Nov 2021183028
Dec 2021122013
Jan 20229002
Feb 2022112035
Mar 2022130015
Apr 2022114013
May 2022108013
Total18070337